JPY 267.0
(-2.55%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -56.22 JPY | 38.01% |
2022 | -90.69 JPY | 2.9% |
2021 | -93.40 JPY | 12.88% |
2020 | -107.21 JPY | -21.91% |
2019 | -87.94 JPY | 15.05% |
2018 | -103.52 JPY | -160.56% |
2017 | -39.73 JPY | 52.89% |
2016 | -84.33 JPY | -229.41% |
2015 | -25.60 JPY | -80.66% |
2014 | -14.17 JPY | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -5.92 JPY | 79.63% |
2024 Q1 | -29.06 JPY | -25.15% |
2023 Q4 | -23.22 JPY | -132.67% |
2023 FY | - JPY | 38.01% |
2023 Q2 | -10.37 JPY | 9.59% |
2023 Q1 | -11.47 JPY | 42.22% |
2023 Q3 | -9.98 JPY | 3.76% |
2022 Q1 | -26.50 JPY | -14.62% |
2022 Q4 | -19.85 JPY | -60.99% |
2022 FY | - JPY | 2.9% |
2022 Q3 | -12.33 JPY | 62.24% |
2022 Q2 | -32.65 JPY | -23.21% |
2021 Q3 | -34.86 JPY | -108.87% |
2021 FY | - JPY | 12.88% |
2021 Q1 | -19.92 JPY | 31.64% |
2021 Q2 | -16.69 JPY | 16.21% |
2021 Q4 | -23.12 JPY | 33.68% |
2020 FY | - JPY | -21.91% |
2020 Q4 | -29.14 JPY | -6.62% |
2020 Q3 | -27.33 JPY | -4.35% |
2020 Q2 | -26.19 JPY | -6.38% |
2020 Q1 | -24.62 JPY | 1.32% |
2019 FY | - JPY | 15.05% |
2019 Q2 | -20.98 JPY | -15.4% |
2019 Q1 | -18.18 JPY | 13.8% |
2019 Q3 | -20.00 JPY | 4.67% |
2019 Q4 | -24.95 JPY | -24.75% |
2018 Q4 | -21.09 JPY | -41.16% |
2018 FY | - JPY | -160.56% |
2018 Q2 | -56.31 JPY | -400.98% |
2018 Q1 | -11.24 JPY | 4.75% |
2018 Q3 | -14.94 JPY | 73.47% |
2017 Q1 | -12.80 JPY | -58.42% |
2017 Q4 | -11.80 JPY | 44.0% |
2017 Q2 | 4.47 JPY | 134.92% |
2017 Q3 | -21.07 JPY | -571.36% |
2017 FY | - JPY | 52.89% |
2016 Q1 | -52.44 JPY | -466.92% |
2016 FY | - JPY | -229.41% |
2016 Q4 | -8.08 JPY | 27.6% |
2016 Q3 | -11.16 JPY | 12.47% |
2016 Q2 | -12.75 JPY | 75.69% |
2015 Q4 | -9.25 JPY | -89.55% |
2015 Q1 | -7.18 JPY | 0.0% |
2015 Q2 | -5.22 JPY | 27.3% |
2015 Q3 | -4.88 JPY | 6.51% |
2015 FY | - JPY | -80.66% |
2014 FY | - JPY | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
KOHJIN BIO CO LTD | 92.20 JPY | 160.976% |
PRISM BioLab Co.,LTD | -14.90 JPY | -277.315% |
GNI Group Ltd. | 169.50 JPY | 133.168% |
Linical Co., Ltd. | 14.98 JPY | 475.3% |
Trans Genic Inc. | 0.24 JPY | 23525.0% |
MEDINET Co., Ltd. | -6.65 JPY | -745.414% |
Soiken Holdings Inc. | -25.32 JPY | -122.038% |
Cytori Cell Research Institute, Inc. | 15.47 JPY | 463.413% |
AnGes, Inc. | -39.29 JPY | -43.09% |
OncoTherapy Science, Inc. | -6.05 JPY | -829.256% |
Nxera Pharma Co., Ltd. | -87.17 JPY | 35.505% |
Immuno-Biological Laboratories Co., Ltd. | 20.05 JPY | 380.399% |
NanoCarrier Co., Ltd. | -11.10 JPY | -406.486% |
Carna Biosciences, Inc. | -68.62 JPY | 18.071% |
CanBas Co., Ltd. | -67.87 JPY | 17.165% |
D. Western Therapeutics Institute, Inc. | -25.56 JPY | -119.953% |
RaQualia Pharma Inc. | -14.98 JPY | -275.3% |
Chiome Bioscience Inc. | -24.62 JPY | -128.351% |
Kidswell Bio Corporation | -40.23 JPY | -39.746% |
PeptiDream Inc. | 23.41 JPY | 340.154% |
Oncolys BioPharma Inc. | -108.92 JPY | 48.384% |
Ribomic Inc. | -28.70 JPY | -95.889% |
SanBio Company Limited | -40.48 JPY | -38.883% |
BrightPath Biotherapeutics Co., Ltd. | -18.21 JPY | -208.731% |
Kubota Pharmaceutical Holdings Co., Ltd. | -26.79 JPY | -109.854% |
Delta-Fly Pharma, Inc. | -198.72 JPY | 71.709% |
StemRIM | -32.98 JPY | -70.467% |
CellSource Co., Ltd. | 48.88 JPY | 215.016% |
FunPep Company Limited | -39.63 JPY | -41.862% |
Kringle Pharma, Inc. | -158.46 JPY | 64.521% |
Stella Pharma Corporation | -24.66 JPY | -127.981% |
TMS Co., Ltd. | -26.02 JPY | -116.065% |
Noile-Immune Biotech Inc. | -27.25 JPY | -106.312% |
Cuorips Inc. | -85.87 JPY | 34.529% |
K Pharma,Inc. | 22.43 JPY | 350.646% |
Takara Bio Inc. | 12.29 JPY | 557.445% |
ReproCELL Incorporated | -0.37 JPY | -15094.595% |
PhoenixBio Co., Ltd. | 6.88 JPY | 917.151% |
StemCell Institute Inc. | 30.25 JPY | 285.851% |
Japan Tissue Engineering Co., Ltd. | 3.53 JPY | 1692.635% |
CellSeed Inc. | -29.43 JPY | -91.03% |